相似文献
1
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
J Clin Microbiol. 2000 Oct;38(10):3900-1. doi: 10.1128/JCM.38.10.3900-3901.2000.
2
Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1694-6. doi: 10.1164/ajrccm.157.5.9709068.
3
Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
Clin Infect Dis. 1998 Apr;26(4):996-7. doi: 10.1086/517646.
4
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):681-5. doi: 10.1007/s10096-003-1007-2. Epub 2003 Oct 18.
5
Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole.
J Pediatr. 1989 Dec;115(6):1016-9. doi: 10.1016/s0022-3476(89)80762-0.
6
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Pediatr Infect Dis J. 2004 Jun;23(6):584-6. doi: 10.1097/01.inf.0000130741.01940.ff.
7
[Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Jpn J Antibiot. 2007 Dec;60(6):321-34.
8
[A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
Tuberk Toraks. 2006;54(1):75-9.
9
Multi-azole resistance in Aspergillus fumigatus.
Int J Antimicrob Agents. 2006 Nov;28(5):450-3. doi: 10.1016/j.ijantimicag.2006.08.017. Epub 2006 Oct 10.
10
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Antimicrob Agents Chemother. 2008 Jul;52(7):2593-8. doi: 10.1128/AAC.00276-08. Epub 2008 May 12.
引用本文的文献
1
Culture-independent diagnostic approaches for invasive aspergillosis in solid organ transplant recipients.
Korean J Transplant. 2023 Sep 30;37(3):155-164. doi: 10.4285/kjt.23.0043.
2
Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases.
Pathogens. 2023 Mar 14;12(3):456. doi: 10.3390/pathogens12030456.
3
Inborn Errors of Immunity Causing Pediatric Susceptibility to Fungal Diseases.
J Fungi (Basel). 2023 Jan 22;9(2):149. doi: 10.3390/jof9020149.
4
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.
J Fungi (Basel). 2020 Jun 6;6(2):79. doi: 10.3390/jof6020079.
5
The application of next-generation sequencing in diagnosing invasive pulmonary aspergillosis: three case reports.
Am J Transl Res. 2019 Apr 15;11(4):2532-2539. eCollection 2019.
6
Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.
Front Microbiol. 2018 Apr 4;9:661. doi: 10.3389/fmicb.2018.00661. eCollection 2018.
7
Challenges in microbiological diagnosis of invasive infections.
F1000Res. 2017 Feb 17;6. doi: 10.12688/f1000research.10216.1. eCollection 2017.
8
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.
9
Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.
Scientifica (Cairo). 2013;2013:459405. doi: 10.1155/2013/459405. Epub 2013 Jan 14.
10
The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children.
Curr Fungal Infect Rep. 2013 Mar 1;7(1):7-14. doi: 10.1007/s12281-012-0127-5.
本文引用的文献
1
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.
J Clin Microbiol. 1999 Oct;37(10):3223-8. doi: 10.1128/JCM.37.10.3223-3228.1999.
2
Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis.
Clin Infect Dis. 1998 Jun;26(6):1407-12. doi: 10.1086/516343.
3
Detection and identification of fungal pathogens in blood by using molecular probes.
J Clin Microbiol. 1997 Jun;35(6):1353-60. doi: 10.1128/jcm.35.6.1353-1360.1997.
4
Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis.
Pediatr Infect Dis J. 1996 Mar;15(3):232-7. doi: 10.1097/00006454-199603000-00011.
5
Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
J Clin Microbiol. 1995 Dec;33(12):3150-3. doi: 10.1128/jcm.33.12.3150-3153.1995.
6
A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.
J Clin Microbiol. 1995 Feb;33(2):497-500. doi: 10.1128/jcm.33.2.497-500.1995.
7
Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR.
J Clin Microbiol. 1995 May;33(5):1164-8. doi: 10.1128/jcm.33.5.1164-1168.1995.
Zotero 插件